Need for transparency in cancer drug pricing

The recent Senate inquiry into the availability of cancer drugs missed an important point: asking why cancer drugs cost so much, say the authors of an article in the MJA.

“What was notably absent… was an in-depth consideration of why new cancer medicines cost so much, and what can be done about it,” say Narcyz Ghinea and Dr Wendy Lipworth from the Centre for Values, Ethics and the Law in Medicine at the University of Sydney.

“Many new cancer drugs cost more than $100,000 per treatment, and it has been shown in